PIII earnings

P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2026 on Thursday, May 14, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter 2026 Earnings Conference Call Date & Time May 14, 2026, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 International 1-412-317-0692 Ask to be joined into the P3 Health Partners call

Providing 2026 Guidance, Indicating a $10 Million Adjusted EBITDA Midpoint Management to Host Conference Call and Webcast March 26, 2026 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2025, and provided 2026 guidance. "2025 was a year of meaningful progress in repositioning the business. We strengthened our contract economics, improved provider alignment, and built a more disciplined operating foundation. With that work in place, we enter 2026 with a clear path to profitability and approxi

P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for fourth quarter and full year 2025 on Thursday, March 26, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter and Full Year 2025 Earnings Conference Call Date & Time March 26, 2026, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 International 1-412-317-0692 Ask to be joined into t

P3 Reports Continued Operational Progress and Expansion of Care Enablement Model in a Transitional Year $120 to $170 Million EBITDA Expansion Opportunity Strengthens Path to Meaningful Profitability Management to Host Conference Call and Webcast November 14, 2025 at 8:00 AM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2025. "Our core business continues to demonstrate positive momentum in the third quarter, driven by the expansion of our Care Enablement Model," said Aric Coffman, CEO of P3. "Medical cost trends

P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third quarter 2025 and file its Quarterly Report on Form 10-Q on Friday, November 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 5:00am PT/ 8:00am ET the same day. Title & Webcast P3 Health Third Quarter 2025 Earnings Conference Call Date & Time November 14, 2025, 8:00am Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 A

Core Business Demonstrates Strength with Flat Medical Cost Trends Despite Industry Inflation $120-$170 Million in Additional EBITDA Opportunities Identified for 2026 Adjusted Full Year Guidance Reflects Prior Period Headwinds Management to Host Conference Call and Webcast August 14, 2025 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2025. "Our core business continues to strengthen as we execute on our $130 million EBITDA improvement plan," said Aric Coffman, CEO of P3. "While we faced prior period head

P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, August 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/4:30pm ET the same day. Title & Webcast P3 Health Second Quarter Earnings Conference Call Date & Time August 14, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into th

 Affirming 2025 guidance Management to Host Conference Call and Webcast May 15, 2025 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, 2025, and affirmed its 2025 guidance. "Our physician-led care enablement model continues to differentiate P3, delivering meaningful improvements in quality measures and cost management through deeper provider partnerships," said Aric Coffman, CEO of P3. "Our turnaround plan is ahead of schedule, with three of four markets already achieving breakeven or better in Q1. Beyond our ori

P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, May 15, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter Earnings Conference Call Date & Time May 15, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into the P3 Health Partners call

Revenue increased 18% year-over-year to $1.50 billion Affirming 2025 guidance Management to Host Conference Call and Webcast [March 27, 2025] at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient- centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and affirmed its 2025 guidance. "Our business model remains fundamentally strong as we continue to deliver member and top-line growth, quality outcomes, and provider retention," said Aric Coffman, CEO of P3. "With the $130M+ in identified programmatic opportunities advancing our path to financial su

P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for the fourth quarter and full year 2024 on March 27, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter Earnings Conference Call Date & Time March 27, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into the P3 Health Partners call   The conference call will

Revenue increased 26% year-over-year to $362.1 million Third quarter results were affected by lower risk adjustments, higher medical expenses in the current year, and retroactive adjustments Executing key 2025 initiatives with a focus on improvements in profitability metrics Management to Host Conference Call and Webcast November 12, 2024 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2024. "As we execute on our strategic initiatives, we believe P3 will be well-positioned to unlock the value built w

P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third quarter 2024 and file its Quarterly Report on Form 10-Q on Tuesday, November 12, 2024. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Third Quarter Earnings Conference Call Date & Time November 12, 2024, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into the P3 Health Partne

Management to Host Conference Call and Webcast August 7, 2024 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2024. "In the second quarter, we experienced continued growth in our top line while simultaneously enhancing our balance sheet through a successful capital raise," said Aric Coffman, CEO of P3. "Building on P3's key strengths, I have identified several initiatives during my first 90 days as CEO that will further enhance our capabilities and help achieve sustainable profitability." Second Quarter 2024

P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2024 and file its Quarterly Report on Form 10-Q on Wednesday, August 7, 2024. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Second Quarter Earnings Conference Call Date & Time August 7, 2024, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into th

Dr. Aric Coffman joins P3 Health Partners as CEO Total revenue growth of 29% year-over-year Reaffirming 2024 guidance Anticipates reaching Adjusted EBITDA positive in 2024 Management to Host Conference Call and Webcast May 8, 2024 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, 2024. "We reported a strong Q1 which exceeded our internal expectations on the top-line. We believe that we are on track to achieve our full year 2024 guidance," said Dr. Sherif Abdou, Co-Founder of P3. "I am thrilled to welcome

P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2024 and file its Quarterly Report on Form 10-Q on Wednesday, May 8, 2024. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter Earnings Conference Call Date & Time May 8, 2024, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into the P3 Hea

Total revenue growth of 21% year-over-year, beating our 2023 guidance Affirming 2024 guidance Anticipates reaching Adjusted EBITDA positive in 2024 Management to Host Conference Call and Webcast March 28, 2024 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2023, and affirmed its 2024 guidance. "Top line results for 2023 were strong as the team executed and delivered with revenue of approximately $1.27 billion, representing 21% growth and exceeding the top end of our guidance range. We

P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for the fourth quarter and full year 2023 on March 28, 2024 and is reaffirming its 2024 guidance. The Company expects to file its Annual Report on Form 10-K for the year ended December 31, 2023, with the SEC within the extension period provided by Rule 12b-25 of the Exchange Act of 1934, as amended, and will host a conference call to discuss full financial results and current business outlook after the close of the stock market on March 28, 2024. Title & Webcast P3 Health Fourth

YTD total revenue growth of 16% Continued strong performance across markets, re-affirming 2023 guidance Provides preliminary 2024 Full-Year Adjusted EBITDA guidance of +$20 million to +$40 million Management to Host Conference Call and Webcast November 8, 2023 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2023. "Our results for the third quarter show the continued improvement of the business as providers and patients mature on our platform. All key metrics are tracking as expected and net cash used

Management to host investor call and webcast at 4:30pm ET on November 8, 2023 P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for third-quarter 2023 and file its Quarterly Report on Form 10-Q on Wednesday, November 8, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update: Title & Webcast P3 Health Third-Quarter 2023 Earnings Conference Call Date & Time November 8, 2023, 4:30pm Eastern Time Conference Call Details Toll-F

Management to Host Conference Call and Webcast August 7, 2023 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2023. "The results for the second quarter of 2023 show the power and trajectory of the P3 model. I'm delighted to say we had solid improvement across all key metrics. The strength we have seen in 2023 has given us the stability and momentum to drive our next phase of success in 2024, and beyond," said Dr. Sherif Abdou, CEO of P3. "We experienced approximately 1% medical cost trend for the quarter. Th

Management to host investor call and webcast at 4:30pm ET on August 7, 2023 P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for second-quarter 2023 and file its quarterly report on Form 10-Q on Monday, August 7, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update: Title & Webcast P3 Health Second-Quarter 2023 Earnings Conference Call Date & Time August 7, 2023, 4:30pm Eastern Time Conference Call Details Toll-Free 1-8

-Capitated revenue increases 11% vs. the same period in the prior year -Q1 2023 operating loss improved 7% vs. the same period in the prior year -Q1 2023 medical margin improvement of 58% vs. the same period in the prior year -Increases Adjusted EBITDA guidance Management to Host Conference Call and Webcast May 10, 2023 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, 2023. "We are off to a strong start in 2023. We achieved a medical margin of $39.2 million or 13.1% as a percentage of capitated revenu

Management to host investor call and webcast at 4:30pm ET on May 10, 2023 P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for first-quarter 2023 and file its quarterly report on Form 10-Q on Wednesday, May 10, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update: Title & Webcast P3 Health First-Quarter 2023 Earnings Conference Call Date & Time May 10, 2023, 4:30pm Eastern Time Conference Call Details Toll-Free 1-877-27

Affirming 2023 guidance – introducing year-end medical margin guidance Anticipates reaching Adjusted EBITDA positive in early 2024 Management to Host Conference Call and Webcast March 31, 2023 at 8:30 AM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2022. "Results for 2022 are a testament to the strength of the P3 team and its commitment to improving clinical outcomes," said Dr. Sherif Abdou, CEO of P3 Health Partners. "We achieved revenue growth and a network contribution improvement of 65% versus 2021

Management to host investor call and webcast on March 31, 2023 at 8:30 AM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, announced that it will now release results for fourth-quarter 2022 and full-year ended December 31, 2022 on Friday, March 31, 2023 before the market open. In connection with this release, management will host a conference call and webcast on Friday, March 31, 2023 at 8:30 AM Eastern Time to provide a corporate and financial update. The call details are below: Title & Webcast P3 Health Fourth-Quarter and Full-Year 2022 Earnings Conference Call Date & Time March 31,

Management to host investor call and webcast at 4:30pm ET on that day P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, announces that the Company expects to release its financial results for fourth-quarter 2022 and full-year ended December 31, 2022 and file its Annual Report on Form 10-K on Thursday, March 30, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update: Title & Webcast P3 Health Fourth-Quarter and Full-Year 2022 Earnings Conference Call Date & Time March 30, 2023, 4:30pm Eastern Time Conference

Strong Third-Quarter YTD 2022 revenue growth of 59% compared to the Third-Quarter YTD 2021 At-risk Medicare Advantage members exceeded 101,000 at the end of the Third Quarter of 2022 Third-Quarter YTD 2022 Net loss PMPM increased to $1,132 from $159 for Third-quarter YTD 2021, primarily due to an $851.5 million goodwill impairment charge recorded in the Second Quarter of 2022 Adjusted EBITDA loss PMPM improved in first nine months of 2022 at a PMPM loss of $97 compared to a PMPM loss of $110 in the first nine months of 2021 Providing Updated Full-Year 2023 Adjusted EBITDA guidance Management to Host Conference Call and Webcast November 14, 2022, at 4:30 PM ET P3 Health Partners

Management to Host Conference Call and Webcast Monday November 14, 2022 at 4:30pm Eastern Time P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company expects to release its financial results for the third quarter ended September 30, 2022 on Monday, November 14, 2022. In connection with this announcement, management will host a conference call and provide a corporate and financial update. Details for the conference call are as follows. Title & Webcast P3 Health Third Quarter 2022 Earnings Conference Call Date & Time November 14, 2022, 4:30pm Eastern Time Con

Strong First-Half 2022 revenue growth of 84% compared to the First-Half 2021At-risk Medicare Advantage members exceeded 100,000 at the end of the First Half of 2022Net loss PMPM increased to $1,580 in the First Half of 2022 from $135 in the First Half of 2021, primarily due to an $851.5 goodwill impairment chargeAdjusted EBITDA loss PMPM improved significantly in First Half of 2022 at a loss of $78 compared to a PMPM loss of $85 in the First Half of 2021Raising Full-Year 2022 revenue guidance Management to Host Conference Call and Webcast on October 20, 2022 at 4:30 PM ET HENDERSON, Nev., Oct. 20, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners, Inc. ("P3" or the "Company") (NASDAQ:PIII), a

Management to Host Conference Call and Webcast Thursday October 20, 2022 at 4:30pm Eastern Time HENDERSON, Nev., Oct. 20, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners, Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company expects to release its financial results for the three and six months ended June 30, 2022 on Thursday, October 20, 2022. In connection with this announcement, management will host a conference call and provide a corporate and financial update. Details for the conference call are as follows. Title & WebcastP3 Health Partners 1H 2022 Financial Results Date & TimeOctober 20, 2

HENDERSON, Nev., April 14, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners, Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company expects to release its financial results for the fourth quarter and full year ended December 31, 2021 on Monday April 25, 2022 after the market closes. Management will host a conference call and webcast at 4:30 PM ET to provide a corporate and financial update. Title & WebcastP3 Health Partners Fourth Quarter and Full Year 2021 Results Conference Call and WebcastDate & TimeMonday April 25, 2022 at 4:30 PM ETConference Call DetailsToll-Free 1-877-407-4018 (US)Interna

Strong revenue growth of 46% for the fourth quarter and 32% for full year 2021 Full year 2022 revenue expected to be up to $1 billion, a 56% increase vs. prior year At-risk Medicare Advantage members expected to be up 95,000 by end of full year 2022, a 42% increase vs. prior year Significant improvements in full year 2022 Adjusted EBITDA PMPM, with Adjusted EBITDA profitability expected in 2024 HENDERSON, Nev., March 09, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners, Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its select preliminary unaudited financial results and business updates for the fourth qu